Alvaro Avezum

Summary

Publications

  1. ncbi request reprint Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)
    Alvaro Avezum
    Dante Pazzanese Cardiology Institute, Research Division, Sao Paulo, Brazil
    Am Heart J 149:67-73. 2005
  2. ncbi request reprint [Risk factors associated with acute myocardial infarction in the São Paulo metropolitan region: a developed region in a developing country]
    Alvaro Avezum
    Instituto Dante Pazzanese de Cardiologia, Hospital do Coração, Sao Paulo, SP
    Arq Bras Cardiol 84:206-13. 2005
  3. ncbi request reprint Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation
    Elizabete Silva dos Santos
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 96:179-87. 2011
  4. doi request reprint Acute coronary syndrome behavior: results of a Brazilian registry
    Leopoldo Soares Piegas
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 100:502-10. 2013
  5. doi request reprint Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry)
    Alvaro Avezum
    Dante Pazzanese Institute of Cardiology, Research Division, Sao Paulo, Sao Paulo, Brazil
    Am J Cardiol 102:1577-82. 2008
  6. ncbi request reprint Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification
    Gustavo B F Oliveira
    Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil
    Am Heart J 153:493-9. 2007
  7. ncbi request reprint The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
    J Antonio Marin-Neto
    Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Mem Inst Oswaldo Cruz 104:319-24. 2009
  8. ncbi request reprint Risk factors for myocardial infarction in Brazil
    Leopoldo S Piegas
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Am Heart J 146:331-8. 2003
  9. ncbi request reprint [The impact of diabetes mellitus on the mortality of acute coronary syndromes]
    Juarez R de Braga
    Divisão de Pesquisa, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Endocrinol Metabol 51:275-80. 2007
  10. ncbi request reprint [Electrical cardioversion and myocardial injury: evaluation by new cardiac injury markers]
    Elizabete Silva dos Santos
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP
    Arq Bras Cardiol 86:191-7. 2006

Detail Information

Publications40

  1. ncbi request reprint Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE)
    Alvaro Avezum
    Dante Pazzanese Cardiology Institute, Research Division, Sao Paulo, Brazil
    Am Heart J 149:67-73. 2005
    ..Evidence-based cardiac therapies are underutilized in elderly patients. We assessed differences in practice patterns, comorbidities, and in-hospital event rates, by age and type of acute coronary syndrome (ACS)...
  2. ncbi request reprint [Risk factors associated with acute myocardial infarction in the São Paulo metropolitan region: a developed region in a developing country]
    Alvaro Avezum
    Instituto Dante Pazzanese de Cardiologia, Hospital do Coração, Sao Paulo, SP
    Arq Bras Cardiol 84:206-13. 2005
    ..To identify the risk factors associated with acute myocardial infarction (AMI) and their respective powers of association in the São Paulo metropolitan region...
  3. ncbi request reprint Comparison between cardiac troponin I and CK-MB mass in acute coronary syndrome without st elevation
    Elizabete Silva dos Santos
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 96:179-87. 2011
    ..There is uncertainty as to the comparative prognostic value between cardiac troponin I (cTnI) and CK-MB in acute coronary syndrome (ACS)...
  4. doi request reprint Acute coronary syndrome behavior: results of a Brazilian registry
    Leopoldo Soares Piegas
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 100:502-10. 2013
    ..Brazil lacks published multicenter registries of acute coronary syndrome...
  5. doi request reprint Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry)
    Alvaro Avezum
    Dante Pazzanese Institute of Cardiology, Research Division, Sao Paulo, Sao Paulo, Brazil
    Am J Cardiol 102:1577-82. 2008
    ..57, 95% confidence interval 1.27 to 1.95). In conclusion, development of VA during hospitalization for acute coronary syndrome was associated with higher in-hospital and 6-month mortalities...
  6. ncbi request reprint Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification
    Gustavo B F Oliveira
    Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil
    Am Heart J 153:493-9. 2007
    ..Our objective was to evaluate the relationship between risk stratification and therapeutic decision making in patients with non-ST-segment elevation acute coronary syndromes...
  7. ncbi request reprint The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
    J Antonio Marin-Neto
    Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Ribeirao Preto, SP, Brasil
    Mem Inst Oswaldo Cruz 104:319-24. 2009
    ..The full-scale study determines whether antitrypanosomal therapy with benznidazole reduces mortality and other major cardiovascular clinical outcomes in patients with chronic Chagas heart disease...
  8. ncbi request reprint Risk factors for myocardial infarction in Brazil
    Leopoldo S Piegas
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
    Am Heart J 146:331-8. 2003
    ..Brazil is one of the largest countries in Latin America and the contemporary evaluation of risk factors for AMI is crucial for a more efficacious disease management...
  9. ncbi request reprint [The impact of diabetes mellitus on the mortality of acute coronary syndromes]
    Juarez R de Braga
    Divisão de Pesquisa, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP, Brazil
    Arq Bras Endocrinol Metabol 51:275-80. 2007
    ....
  10. ncbi request reprint [Electrical cardioversion and myocardial injury: evaluation by new cardiac injury markers]
    Elizabete Silva dos Santos
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP
    Arq Bras Cardiol 86:191-7. 2006
    ..Evaluate, based on the evolution of new biochemical markers of cardiac damage, if electrical cardioversion (ECV) causes myocardial injury...
  11. doi request reprint Risk factors for pre, intra, and postoperative hospital mortality in patients undergoing aortic surgery
    Mario Issa
    Dante Pazzanese Institute of Cardiology São Paulo, SP, Brazil
    Rev Bras Cir Cardiovasc 28:10-21. 2013
    ..The secondary objective was to identify factors associated with clinical outcome composed hospital (death, bleeding, neurologic complications or ventricular dysfunction)...
  12. doi request reprint Cardiovascular prevention in coronary heart disease patients: guidelines implementation in clinical practice
    Clarisse Kaoru Ogawa Indio do Brasil
    Medical Unit of Coronary Diseases at Dante Pazzanese Institute of Cardiology, Sao Paulo, SP, Brazil
    Rev Bras Cir Cardiovasc 28:238-47. 2013
    ....
  13. doi request reprint Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
    Jose Antonio Marin-Neto
    Medical School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
    Am Heart J 156:37-43. 2008
    ..However, the efficacy of trypanocidal therapy in preventing clinical complications in patients with preexisting cardiac disease is unknown...
  14. pmc Brazilian Sepsis Epidemiological Study (BASES study)
    Eliezer Silva
    Intensive Care Unit, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
    Crit Care 8:R251-60. 2004
    ..This study was designed to verify the actual incidence density and outcome of sepsis in Brazilian ICUs. We also assessed the association between the Consensus Conference criteria and outcome..
  15. ncbi request reprint [Evidence based cardiology. Some necessary clarifications]
    Otavio Berwanger
    Centro de Pesqusa Clínica, IEP, Hospital Albert Einstein, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP
    Arq Bras Cardiol 83:357-9. 2004
  16. ncbi request reprint [Evidence-based cardiology: where to find evidence]
    Otavio Berwanger
    Instituto Dante Pazzanese de Cardiologia, Sao Paulo, SP
    Arq Bras Cardiol 86:56-60. 2006
  17. ncbi request reprint Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)
    David Brieger
    Concord Hospital, Sydney, Australia
    Am Heart J 153:960-9. 2007
    ....
  18. doi request reprint Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events
    Gerard Devlin
    Department of Cardiology, Waikato Hospital, Hamilton, New Zealand
    Eur Heart J 29:1275-82. 2008
    ....
  19. ncbi request reprint Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction
    Rajendra H Mehta
    University of Michigan, Ann Arbor, Mich, USA
    Am Heart J 147:253-9. 2004
    ....
  20. ncbi request reprint Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study
    Fernando Lanas
    Facultad de Medicina, Universidad de La Frontera M, Montt 112 Temuco, Chile
    Circulation 115:1067-74. 2007
    ..Current knowledge of the impact of cardiovascular risk factors in Latin America is limited...
  21. ncbi request reprint Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl
    Frederick A Spencer
    Department of Medicine, McMaster University, Faculty of Health Sciences, Hamilton, Ontario, Canada, and Coronary Care Unit, Concord Hospital, Sydney, Australia
    Am J Cardiol 100:913-8. 2007
    ....
  22. ncbi request reprint A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry
    Kim A Eagle
    Department of Internal Medicine, University of Michigan Health System, Ann Arbor, USA
    JAMA 291:2727-33. 2004
    ..Accurate estimation of risk for untoward outcomes after patients have been hospitalized for an acute coronary syndrome (ACS) may help clinicians guide the type and intensity of therapy...
  23. ncbi request reprint Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2
    Dorairaj Prabhakaran
    McMaster University, Hamilton, Canada
    Indian Heart J 57:217-25. 2005
    ..This study sought to compare baseline characteristics, practice patterns and clinical outcomes for patients with non-ST elevation acute coronary syndrome from a broad range of low-, middle- and high-income countries...
  24. ncbi request reprint Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE)
    Gilles Montalescot
    Service de cardiologie, Pitie Salpetriere Hospital, Paris, France
    Catheter Cardiovasc Interv 60:360-7. 2003
    ..4% among patients who received neither GP IIb/IIIa inhibitors nor a stent, compared to patients who received both GP IIb/IIIa inhibitors and a stent (7.3%), GP IIb/IIIa inhibitors alone (12.8%), or a stent alone (6.7%)...
  25. ncbi request reprint Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)
    Robert J Goldberg
    University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Am J Cardiol 89:791-6. 2002
    ....
  26. doi request reprint Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure
    Philippe Gabriel Steg
    INSERM U 698, Recherche Clinique en Athérothrombose, Universite Paris VII, Centre Hospitalier Bichat Claude Bernard, 46 rue Henri Huchard, 75877 Paris, Cedex 18, France
    Circulation 118:1163-71. 2008
    ..The aims of this study were to describe the use of revascularization in non-ST-elevation acute coronary syndrome and CHF and to analyze its impact on survival...
  27. ncbi request reprint [C-reactive protein and cardiovascular disease. Basis of scientific evidence]
    Wellington Bruno Santos
    Universidade Federal Fluminense, Niterio, RJ
    Arq Bras Cardiol 80:452-6. 2003
  28. ncbi request reprint Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
    J Malcolm O Arnold
    London Health Sciences Centre, London, Canada
    Circulation 107:1284-90. 2003
    ..We assessed an angiotensin-converting enzyme (ACE) inhibitor, ramipril, to prevent the development of heart failure in high-risk patients without known low ejection fraction or heart failure...
  29. ncbi request reprint Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction
    Rafael Diaz
    Etudios Cardiologica Latin America, Rosario, Argentina
    JAMA 298:2399-405. 2007
    ..While some smaller trials suggest benefit, in the CREATE-ECLA trial, GIK infusion had no effect on 30-day mortality in 20,201 patients...
  30. ncbi request reprint Predictors of hospital mortality in the global registry of acute coronary events
    Christopher B Granger
    Division of Cardiology, University Medical Center, Durham, NC, USA
    Arch Intern Med 163:2345-53. 2003
    ..Management of acute coronary syndromes (ACS) should be guided by an estimate of patient risk...
  31. ncbi request reprint Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)
    Debabrata Mukherjee
    Gill Heart Institute and the University of Kentucky, Lexington, Kentucky, USA
    Am J Cardiol 100:1-6. 2007
    ..In conclusion, outcomes after ACS are worse in patients with PAD or stroke, with the highest risk in patients with the 2 conditions and the use of evidence-based therapies are associated with improved outcomes in all ACS subgroups...
  32. ncbi request reprint Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
    Salim Yusuf
    Population Health Research Institute, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, Canada L8L 2X2
    Lancet 364:937-52. 2004
    ..Therefore, the effect of such factors on risk of coronary heart disease in most regions of the world is unknown...
  33. ncbi request reprint Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial
    James J Ferguson
    JAMA 292:45-54. 2004
    ..Enoxaparin has demonstrated advantages over unfractionated heparin in low- to moderate-risk patients with non-ST-segment elevation acute coronary syndromes (ACS) treated with a conservative strategy...
  34. pmc Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study
    Frans Van de Werf
    Universitair Ziekenhuis Gasthuisberg, Herestraat 49, Leuven, Belgium 3000
    BMJ 330:441. 2005
    ..To investigate the relation between access to a cardiac catheterisation laboratory and clinical outcomes in patients admitted to hospital with suspected acute coronary syndrome...
  35. ncbi request reprint Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study
    Kim A Eagle
    University of Michigan Cardiovascular Center, Ann Arbor, Michigan, USA
    Am J Med 117:73-81. 2004
    ..To determine the rates of patient adherence to key evidence-based therapies at 6 months after hospital discharge for an acute coronary syndrome...
  36. ncbi request reprint Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE)
    James B Froehlich
    University of Michigan Health System, Ann Arbor, MI, USA
    Am Heart J 151:1123-8. 2006
    ..The objectives of this study were to assess treatment practices and hospital outcomes in patients with ACS and prior PAD...
  37. ncbi request reprint Effect of ramipril on the incidence of diabetes
    Jackie Bosch
    McMaster University, Hamilton, Canada
    N Engl J Med 355:1551-62. 2006
    ..Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension...
  38. pmc Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
    Keith A A Fox
    Royal Infirmary of Edinburgh, University of Edinburgh, Edinburgh EH16 4SB
    BMJ 333:1091. 2006
    ..To develop a clinical risk prediction tool for estimating the cumulative six month risk of death and death or myocardial infarction to facilitate triage and management of patients with acute coronary syndrome...
  39. ncbi request reprint Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
    Andrzej Budaj
    Postgraduate Medical School, Grochowski Hospital Warsaw, Poland
    Am Heart J 146:999-1006. 2003
    ..The objective of this report was to describe patterns of use of antithrombotic and antiplatelet therapies in patients with the spectrum of ACS through the use of data from the Global Registry of Acute Coronary Events (GRACE)...
  40. ncbi request reprint Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)
    Kim A Eagle
    Division of Cardiology, University Hospital, Ann Arbor, MI 48109 0366, USA
    Lancet 359:373-7. 2002
    ..This study assessed current practices in relation to reperfusion therapy of ST-segment-elevation myocardial infarction from data collected in the multinational, prospective Global Registry of Acute Coronary Events...